Cart
sales@molnova.com
GS-9695
CAS No. 1471256-08-2
GS-9695( GS9695 | GS 9695 )
Catalog No. M12018 CAS No. 1471256-08-2
GS-9695 is a potent, non-catalytic site HIV integrase inhibitor with wild type EC50 of 1.2 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGS-9695
-
NoteResearch use only, not for human use.
-
Brief DescriptionGS-9695 is a potent, non-catalytic site HIV integrase inhibitor with wild type EC50 of 1.2 nM.
-
DescriptionGS-9695 is a potent, non-catalytic site HIV integrase inhibitor with wild type EC50 of 1.2 nM.
-
In Vitro——
-
In Vivo——
-
SynonymsGS9695 | GS 9695
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1471256-08-2
-
Formula Weight594.171
-
Molecular FormulaC31H36ClN5O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(S)-2-(tert-butoxy)-2-(7-(4-chlorophenyl)-2-(6-(4-isopropylpiperazin-1-yl)pyrazin-2-yl)-5-methylbenzo[d]thiazol-6-yl)acetic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Ritonavir
A potent HIV protease inhibitor for treatment of HIV-1 infection.
-
TAK-779
TAK-779 is a potent, specific, nonpeptide CCR5 antagonist with Kd of 0.45 nM.
-
BMS-488043
BMS-488043 is a novel and unique oral small molecule HIV fusion inhibitor that inhibits the attachment of Human Immunodeficiency Virus type 1 (HIV-1) to CD4(+) lymphocytes.
